High-throughput, signature-tagged mutagenic approach to identify novel virulence factors of Yersinia pestis CO92 in a mouse model of infection

Infection and Immunity
Duraisamy PonnusamyA K Chopra

Abstract

The identification of new virulence factors in Yersinia pestis and understanding their molecular mechanisms during an infection process are necessary in designing a better vaccine or to formulate an appropriate therapeutic intervention. By using a high-throughput, signature-tagged mutagenic approach, we created 5,088 mutants of Y. pestis strain CO92 and screened them in a mouse model of pneumonic plague at a dose equivalent to 5 50% lethal doses (LD50) of wild-type (WT) CO92. From this screen, we obtained 118 clones showing impairment in disseminating to the spleen, based on hybridization of input versus output DNA from mutant pools with 53 unique signature tags. In the subsequent screen, 20/118 mutants exhibited attenuation at 8 LD50 when tested in a mouse model of bubonic plague, with infection by 10/20 of the aforementioned mutants resulting in 40% or higher survival rates at an infectious dose of 40 LD50. Upon sequencing, six of the attenuated mutants were found to carry interruptions in genes encoding hypothetical proteins or proteins with putative functions. Mutants with in-frame deletion mutations of two of the genes identified from the screen, namely, rbsA, which codes for a putative sugar transport system ATP-binding p...Continue Reading

References

Sep 5, 1987·Journal of Molecular Biology·B F Horazdovsky, R W Hogg
Jan 1, 1996·Infection and Immunity·S G WilliamsP A Manning
Jun 1, 1996·Protein Science : a Publication of the Protein Society·J ZaitsevaM Hermodson
Jan 1, 1997·Clinical Microbiology Reviews·R D Perry, J D Fetherston
May 12, 2000·JAMA : the Journal of the American Medical Association·T V InglesbyK Tonat
Jun 1, 2000·Proceedings of the National Academy of Sciences of the United States of America·K A Datsenko, B L Wanner
Feb 21, 2002·Infection and Immunity·Yidong DuAke Forsberg
Jul 27, 2002·Journal of Bacteriology·Wen DengRobert D Perry
Aug 7, 2002·The Journal of Cell Biology·Guy R Cornelis
Oct 23, 2002·The Journal of Experimental Medicine·Andreas SingJürgen Heesemann
Oct 1, 1958·Journal of General Microbiology·R BEN-GURION, I HERTMAN
Nov 25, 2005·Proceedings of the National Academy of Sciences of the United States of America·Wyndham W LathemWilliam E Goldman
Jul 26, 2006·Proceedings of the National Academy of Sciences of the United States of America·Florent SebbaneB Joseph Hinnebusch
Nov 15, 2006·Infection and Immunity·Sarah S BubeckPeter H Dube
Dec 2, 2006·Nature Reviews. Genetics·Piotr MazurkiewiczDavid W Holden
May 23, 2007·Proceedings of the National Academy of Sciences of the United States of America·Adam C SilverJoerg Graf
Oct 31, 2007·Advances in Experimental Medicine and Biology·Stephen T Smiley
Nov 21, 2007·Infection and Immunity·Sara Schesser BartraGregory V Plano
Feb 6, 2008·Infection and Immunity·Bei Li, Ruifu Yang
Jun 7, 2008·Microbiology and Molecular Biology Reviews : MMBR·Amy L DavidsonJue Chen
Jan 24, 2009·Current Opinion in Microbiology·Stefan PukatzkiSarah T Miyata
Oct 20, 2009·Infection, Genetics and Evolution : Journal of Molecular Epidemiology and Evolutionary Genetics in Infectious Diseases·Andrey P AnisimovVladimir L Motin

❮ Previous
Next ❯

Citations

Dec 25, 2015·Trends in Microbiology·Roger D PechousWilliam E Goldman
Feb 7, 2018·Frontiers in Immunology·Justyna SobocińskaKatarzyna Kwiatkowska
Jan 12, 2019·Journal of Medical Microbiology·Ali A RabaanShafiul Haque
Nov 28, 2018·Applied and Environmental Microbiology·Clara PliegoCayo Ramos
Aug 16, 2018·Frontiers in Cellular and Infection Microbiology·Xiaobing YangXihui Shen
Nov 2, 2017·Frontiers in Cellular and Infection Microbiology·Jourdan A AnderssonAshok K Chopra
Mar 23, 2021·World Journal of Microbiology & Biotechnology·Abhinay SharmaAtul Kumar Johri
Jun 19, 2021·Applied Microbiology and Biotechnology·Jason A RosenzweigAshok K Chopra

❮ Previous
Next ❯

Related Concepts

Related Feeds

ApoE, Lipids & Cholesterol

Serum cholesterol, triglycerides, apolipoprotein B (APOB)-containing lipoproteins (very low-density lipoprotein (VLDL), immediate-density lipoprotein (IDL), and low-density lipoprotein (LDL), lipoprotein A (LPA)) and the total cholesterol/high-density lipoprotein (HDL) cholesterol ratio are all connected in diseases. Here is the latest research.